FDA Logo links to FDA home page
Center for Biologics Evaluation and Research, U.S. Food and Drug AdministrationU.S. Food and Drug AdministrationCenter for Biologics Evaluation and Research
 HHS Logo links to Department of Health and Human Services website

FDA Home Page | CBER A-Z Index | CBER Search | Contact CBER | CBER Home Page

horizontal rule
CBER links to product areas Blood Vaccines Cellular/Gene Therapy Tissue Devices
CBER links Products Industry Healthcare Reading Room Meetings What's New
horizontal rule

Substantially Equivalent 510(k) Device Information

horizontal rule

Applicant: American Blood Resources Association, Annapolis, MD
510(k) number: BK960030
Product: National Donor Deferral Registry
Date: 03/20/97

horizontal rule

Summary of Safety and Effectiveness

510(k) Statement

I certify that, in my capacity as President of American Blood Resources Association, I will make available all information included in this premarket notification on safety and effectiveness within 30 days of request by any person if the device described in the premarket notification submission is determined to be substantially equivalent. The information I agree to make available will be a duplicate of the premarket notification submission, including any adverse safety and effectiveness information, but excluding all patient identifiers, and trade secret and confidential commercial information, as defined in 21 CFR 20.61.

--- signature ---        __3/29/96_____

James P. Reilly                 (date)
President
American Blood Resources Association

 

 
horizontal rule